International Society for Pharmacoepidemiology
Public records show a registered, tax-exempt organization in good standing.
What it says it does
See Schedule O
- Income
- $3.3 million
- Spending
- $3.8 million
- Spent on programs
- 62%
- Reserves
- 10 months of spending
- Largest source of income
- fees for its services, 96%
- Employees
- 0
- Volunteers
- 91
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Fair: 67 out of 100.
Reserves
28 of 35Spendable reserves would cover 10.0 months of spending.
Debt
16 of 20It owes 18% of what it owns.
Living within its means
0 of 15Spending exceeded income by 18% of income.
Income trend
15 of 15Income rose 24% on the year before.
Spending floor
8 of 1562% of spending went to programs.
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Strong: 100 out of 100.
Independent board
25 of 2520 of 20 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
8 of 8Has a written whistleblower policy.
Record keeping policy
7 of 7Has a written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
10 of 10Gave the board a copy of this return before filing it.
Independent check of accounts
15 of 15Its accounts were audited by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (5)
- $2.3 million spent. Development and management of scientific forums: 1) convene an annual scientific forum (international conference on pharmacoepidemiology & therapeutic risk management - ICPE) where members of the discipline meet to network, present results of methodological investigations and studies in progress, discuss public health policy issues concerning pharmacoepidemiology, therapeutic risk management, and other related fields. 2) Convene regular regional and local meetings on scientific and public policy issues, which currently includes a mid-year conference in conjunction with meetings of the board of directors and scientific program committee; and an annual Asian conference (ACPE) partnered with local scientific and professional societies.
- $24,049 spent. The Societys communications program delivers: 1) a website with significant resources on the expanding science and practice of pharmacoepidemiology, and presents ISPEs goals and objectives to current/prospective members, and the general public; and 2) regular email updates to members on developments in pharmacoepidemiology, or about ISPE.
- $15,141 spent. Publications: 1) The Society provides a members-only subscription to Pharmacoepidemiology and Drug Safety, a leading scientific journal publishing definitive, peer-reviewed papers on the science and practice of pharmacoepidemiology; and 2) a Manuscript Initiative, which funds the development of resource documents focused on pharmacoepidemiology, pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management.
- $14,857 spent. Membership: With membership of over 2000 in more than 50 countries, the Society is the voice of pharmacoepidemiology, pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management. Members gain access to a rich and formidable network of like-minded individuals entirely focused on these issues, combined with career mentoring and professional development.
- $6,480 spent. The Societys education program delivers: 1) on-demand education sessions of a broad range of topics recorded at ISPE conferences and delivered online via the Education Center; and 2) a regular series of webinars based on current and breaking issues in pharmacoepidemiology presented by leading subject matter experts.
Source: Form 990 for the year ending June 30, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending June 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since July 1994.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.